Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

United Therapeutics

United Therapeutics reported $700K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Amarin AMRN:US USD 301.28M 2.28M
Ardelyx ARDX:US USD 21K 1000
Baxter International BAX:US USD 683M 0
Bayer BAYN:GR EUR 2.52B 0
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Emergent BioSolutions EBS:US USD 100K 0
Esperion Therapeutics ESPR:US USD 87K 12K
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Halozyme Therapeutics HALO:US USD 132K 3K
Insmed INSM:US USD 1.36M 7K
Intercept Pharmaceuticals ICPT:US USD 42K 0
Intra Cellular Therapies ITCI:US USD 10K 1000
Ionis Pharmaceuticals IONS:US USD 143K 1000
J&J JNJ:US USD 3.12B 0
Moderna Inc MRNA:US USD 38.4K 100
PTC Therapeutics PTCT:US USD 73K 1000
Sangamo BioSciences SGMO:US USD 1.72M 50K
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 0
Teva Pharmaceutical Industries Ltd TEVA:IT USD 57M 0
United Therapeutics UTHR:US USD 700K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0